Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canada Armenia Trading House (CATH) is a trade facilitation and distribution company focused on bridging the markets of Canada and Armenia, with a specialized emphasis on the healthcare and life sciences sectors. The company acts as a strategic partner for Canadian pharmaceutical and medical device manufacturers, providing essential services such as market entry strategy, regulatory compliance support, and logistics management. CATH is actively involved in the procurement and distribution of Canadian-made medical equipment, diagnostic tools, and therapeutic products to healthcare institutions across Armenia. By leveraging its extensive network of government and private sector contacts, the company aims to improve the quality of medical care in Armenia through the introduction of advanced Canadian healthcare solutions. It serves as a primary conduit for Canadian medical innovation seeking expansion into the South Caucasus and the broader Eurasian Economic Union region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canada Armenia Trading House.